Squadron Capital Management LLC
CIK 2050709 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $322.2M
- Posisi
- 43
- Per tanggal
- 30 Juni 2026
#4.973 dari 9.443 berdasarkan nilai 13F · top 52.7%
Nilai portofolio QoQ: +18.1% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 66,20%
- Bobot 25 kepemilikan teratas
- 90,29%
- Posisi di atas 1%
- 27
- Jumlah posisi efektif
- 15,3
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 35,22% Perkiraan pembelian $128.650.902 · penjualan $104.811.000
- Posisi baru
- 24
- Meningkat
- 11
- Menurun
- 6
- Tertutup
- 15
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 95,0% · Opsi dikecualikan: 6,8%
Rincian sektor
Healthcare
97,1%
Lainnya/Tidak terpetakan
2,9%
Portofolio lengkap 43 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics, Inc. - Common Stock | $50.862.000 | 15,78% | 7.350.000 | $-8.121.014 | Turun ×1 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $33.624.000 | 10,43% | 7.200.000 | $27.706.500 | Naik ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $33.475.500 | 10,39% | 865.000 | $3.164.933 | Naik ×2 | ||
| KOD Kodiak Sciences Inc - Common Stock | $19.480.000 | 6,05% | 500.000 | $4.994.400 | Naik ×2 | ||
| RLAY Relay Therapeutics, Inc. - Common Stock | $18.148.700 | 5,63% | 970.000 | $11.457.325 | Naik ×1 | ||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $17.945.000 | 5,57% | 3.700.000 | $9.448.460 | Naik ×1 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $11.782.700 | 3,66% | 290.000 | $757.700 | Turun ×1 | ||
| MAZE Maze Therapeutics, Inc. - Common Stock | $9.996.400 | 3,10% | 335.000 | $2.310.025 | Naik ×1 | ||
| IVA Inventiva S.A. - American Depository Shares | $9.204.300 | 2,86% | 2.435.000 | $6.235.050 | Naik ×2 | ||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $8.796.074 | 2,73% | 764.876 | $40.676 | Turun ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $8.120.000 | 2,52% | 160.000 | Naik ×1 | |||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $6.357.420 | 1,97% | 183.000 | Opsi beli | $3.819.720 | Naik ×1 | |
| PALI Palisade Bio, Inc. - Common Stock | $6.270.000 | 1,95% | 3.000.000 | $1.020.000 | |||
| BIOA BioAge Labs, Inc. - Common Stock | $6.127.500 | 1,90% | 250.000 | Opsi beli | Naik ×1 | ||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $6.090.000 | 1,89% | 3.000.000 | $210.000 | Turun ×2 | ||
| ADAG Adagene Inc. - ADS, each representing 1.25 ordinary shares | $5.250.000 | 1,63% | 1.250.000 | Naik ×1 | |||
| FBRX Forte Biosciences, Inc. - Common Stock | $4.781.250 | 1,48% | 225.000 | Naik ×1 | |||
| RZLT Rezolute, Inc. - Common Stock (NV) | $4.680.000 | 1,45% | 900.000 | Opsi beli | Naik ×1 | ||
| IFRX InflaRx N.V. - Common Stock | $4.480.000 | 1,39% | 2.000.000 | Naik ×1 | |||
| ASMB Assembly Biosciences, Inc. - Common Stock | $4.396.800 | 1,36% | 160.000 | Naik ×1 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $4.315.750 | 1,34% | 305.000 | Opsi beli | Naik ×1 | ||
| PMN ProMIS Neurosciences Inc. - Common Shares | $4.276.697 | 1,33% | 324.977 | $149.489 | |||
| CTNM Contineum Therapeutics, Inc. - Common stock | $4.261.400 | 1,32% | 260.000 | Naik ×1 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $4.245.000 | 1,32% | 300.000 | ||||
| DFTX Definium Therapeutics, Inc. - Common Shares | $3.998.400 | 1,24% | 85.000 | Naik ×1 | |||
| SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | $3.855.280 | 1,20% | 52.000 | $1.399.460 | Naik ×1 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $3.799.050 | 1,18% | 155.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 811292309) | $3.080.518 | 0,96% | 756.884 | Naik ×1 | |||
| PRQR ProQR Therapeutics N.V. - Ordinary Shares | $2.811.383 | 0,87% | 1.511.496 | Naik ×1 | |||
| IRON Disc Medicine, Inc. - Common Stock | $2.194.200 | 0,68% | 30.000 | Opsi beli | Naik ×1 | ||
| RZLT Rezolute, Inc. - Common Stock (NV) | $2.097.732 | 0,65% | 403.410 | Naik ×1 | |||
| LPCN Lipocine Inc. - Common Stock | $2.073.600 | 0,64% | 810.000 | $-1.521.900 | Naik ×1 | ||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $2.066.100 | 0,64% | 426.000 | Opsi beli | $1.130.100 | Naik ×1 | |
| CCCC C4 Therapeutics, Inc. - Common Stock | $1.868.000 | 0,58% | 400.000 | Opsi beli | Naik ×1 | ||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $1.836.450 | 0,57% | 55.000 | Opsi beli | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 22978P205) | $1.578.000 | 0,49% | 50.000 | Naik ×1 | |||
| CALC CalciMedica, Inc. - Common Stock | $1.282.210 | 0,40% | 1.244.864 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 22053A305) | $734.421 | 0,23% | 40.375 | Naik ×1 | |||
| NVCT Nuvectis Pharma, Inc. - Common Stock | $711.693 | 0,22% | 38.700 | Opsi beli | Naik ×1 | ||
| KTTA Pasithea Therapeutics Corp. - Common Stock | $515.400 | 0,16% | 1.000.000 | $-1.042.380 | Turun ×1 | ||
| INM InMed Pharmaceuticals Inc. - Common Shares | $503.750 | 0,16% | 325.000 | Naik ×1 | |||
| NMRA Neumora Therapeutics, Inc. - Common Stock | $170.000 | 0,05% | 100.000 | Naik ×1 | |||
| NXTC NextCure, Inc. - Common Stock | $103.142 | 0,03% | 64.464 | $-2.727.058 | Turun ×1 | ||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| ELVN | $8.120.000 | 160.000 | 2,52% |
| BIOA | $6.127.500 | 250.000 | 1,90% |
| ADAG | $5.250.000 | 1.250.000 | 1,63% |
| FBRX | $4.781.250 | 225.000 | 1,48% |
| RZLT | $4.680.000 | 900.000 | 1,45% |
| IFRX | $4.480.000 | 2.000.000 | 1,39% |
| ASMB | $4.396.800 | 160.000 | 1,36% |
| CMPS | $4.315.750 | 305.000 | 1,34% |
| CTNM | $4.261.400 | 260.000 | 1,32% |
| CMPS | $4.245.000 | 300.000 | 1,32% |
| DFTX | $3.998.400 | 85.000 | 1,24% |
| BIOA | $3.799.050 | 155.000 | 1,18% |
| Penerbit tidak dikenal (CUSIP: 811292309) | $3.080.518 | 756.884 | 0,96% |
| PRQR | $2.811.383 | 1.511.496 | 0,87% |
| IRON | $2.194.200 | 30.000 | 0,68% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RLAY | Beli lebih banyak | +298K | +$11.5M |
| ZNTL | Beli lebih banyak | +69K | +$9.4M |
| RLMD | Dipangkas | -1.1M | -$8.1M |
| IVA | Beli lebih banyak | +1.9M | +$6.2M |
| KOD | Beli lebih banyak | +120K | +$5.0M |
| AVBP | Beli lebih banyak | +73K | +$3.8M |
| COGT | Beli lebih banyak | +78K | +$3.2M |
| MAZE | Beli lebih banyak | +78K | +$2.3M |
| LPCN | Beli lebih banyak | +360K | -$1.5M |
| SLGL | Beli lebih banyak | +21K | +$1.4M |
2 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| KALV | 30 Juni 2026 | 1.300.100 | $26.171.013 | Tidak lagi dilacak |
| ABVX | 30 Juni 2026 | 130.000 | $14.475.500 | -11,7% |
| NKTR | 30 Juni 2026 | 125.000 | $8.993.750 | 7,2% |
| TERN | 31 Maret 2026 | 190.000 | $7.676.000 | Tidak lagi dilacak |
| IDYA | 30 Juni 2026 | 224.300 | $7.473.676 | 2,3% |
| SCYX | 30 Juni 2026 | 7.608.695 | $6.976.412 | 29,2% |
| TARS | 31 Maret 2026 | 80.000 | $6.550.400 | 3,2% |
| UPB | 31 Maret 2026 | 230.650 | $6.262.148 | -19,0% |
| EPRX | 30 Juni 2026 | 680.000 | $4.923.200 | 6,5% |
| XENE | 31 Maret 2026 | 105.551 | $4.730.796 | 6,0% |
| DBVT | 31 Maret 2026 | 240.000 | $4.600.800 | -31,1% |
| GHRS | 30 Juni 2026 | 325.000 | $4.569.500 | 9,3% |
| HELP | 31 Maret 2026 | 525.000 | $4.294.500 | 154,7% |
| KPTI | 30 Juni 2026 | 750.000 | $4.177.500 | -80,3% |
| BLTE | 31 Maret 2026 | 26.000 | $4.158.960 | 6,3% |
| VTYX | 31 Maret 2026 | 410.000 | $3.702.300 | Tidak lagi dilacak |
| VERA | 31 Maret 2026 | 60.000 | $3.038.400 | -21,5% |
| WVE | 31 Maret 2026 | 175.000 | $2.975.000 | -26,3% |
| ALXO | 30 Juni 2026 | 1.460.000 | $2.927.300 | -3,1% |
| CNTX | 30 Juni 2026 | 1.100.000 | $2.882.000 | -11,0% |
| CMPS | 31 Maret 2026 | 388.287 | $2.679.180 | 153,1% |
| AVTX | 31 Maret 2026 | 130.000 | $2.360.800 | 35,8% |
| ZBIO | 31 Maret 2026 | 36.000 | $1.307.160 | 52,9% |
| TRAW | 30 Juni 2026 | 511.714 | $936.437 | -36,0% |
| TXMD | 30 Juni 2026 | 420.421 | $849.250 | -6,8% |
| SPRB | 30 Juni 2026 | 12.200 | $797.270 | -4,8% |
| NTLA | 31 Maret 2026 | 81.000 | $728.190 | -1,1% |
| HOWL | 30 Juni 2026 | 563.535 | $469.199 | 15,3% |
| CLYM | 31 Maret 2026 | 100.000 | $400.000 | 150,1% |
| NEUP | 30 Juni 2026 | 76.728 | $312.283 | -8,5% |